A short-term in vitro drug sensitivity assay in pediatric malignancies

C. Rosanda, A. Garaventa, M. Pasino, P. Strigini, B. De Bernardi

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

A short-term in vitro chemosensitivity test has been applied to 131 specimens from 109 children with various malignancies. The clinical outcome was correlated with in vitro percentage inhibition (PI) of DNA synthesis by the drug tested. In 62 correlations, PIs of responsive and of resistant patients differed significantly, with a cuf-off value of 37%. The test predicted clinical resistance in 53/54 cases, with a specificity of 98%, and clinical response in 8/8 cases, with a sensitivity of 100%. This test can be useful particularly in predicting chemoresistance in relapsing patients, to avoid unnecessary toxicity.

Original languageEnglish
Pages (from-to)365-367
Number of pages3
JournalAnticancer Research
Volume7
Issue number3 B
Publication statusPublished - 1987

Fingerprint

Pediatrics
Pharmaceutical Preparations
Neoplasms
DNA
In Vitro Techniques

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Rosanda, C., Garaventa, A., Pasino, M., Strigini, P., & De Bernardi, B. (1987). A short-term in vitro drug sensitivity assay in pediatric malignancies. Anticancer Research, 7(3 B), 365-367.

A short-term in vitro drug sensitivity assay in pediatric malignancies. / Rosanda, C.; Garaventa, A.; Pasino, M.; Strigini, P.; De Bernardi, B.

In: Anticancer Research, Vol. 7, No. 3 B, 1987, p. 365-367.

Research output: Contribution to journalArticle

Rosanda, C, Garaventa, A, Pasino, M, Strigini, P & De Bernardi, B 1987, 'A short-term in vitro drug sensitivity assay in pediatric malignancies', Anticancer Research, vol. 7, no. 3 B, pp. 365-367.
Rosanda C, Garaventa A, Pasino M, Strigini P, De Bernardi B. A short-term in vitro drug sensitivity assay in pediatric malignancies. Anticancer Research. 1987;7(3 B):365-367.
Rosanda, C. ; Garaventa, A. ; Pasino, M. ; Strigini, P. ; De Bernardi, B. / A short-term in vitro drug sensitivity assay in pediatric malignancies. In: Anticancer Research. 1987 ; Vol. 7, No. 3 B. pp. 365-367.
@article{88ac62a00ce1476d82e0c19c4a0a806e,
title = "A short-term in vitro drug sensitivity assay in pediatric malignancies",
abstract = "A short-term in vitro chemosensitivity test has been applied to 131 specimens from 109 children with various malignancies. The clinical outcome was correlated with in vitro percentage inhibition (PI) of DNA synthesis by the drug tested. In 62 correlations, PIs of responsive and of resistant patients differed significantly, with a cuf-off value of 37{\%}. The test predicted clinical resistance in 53/54 cases, with a specificity of 98{\%}, and clinical response in 8/8 cases, with a sensitivity of 100{\%}. This test can be useful particularly in predicting chemoresistance in relapsing patients, to avoid unnecessary toxicity.",
author = "C. Rosanda and A. Garaventa and M. Pasino and P. Strigini and {De Bernardi}, B.",
year = "1987",
language = "English",
volume = "7",
pages = "365--367",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "3 B",

}

TY - JOUR

T1 - A short-term in vitro drug sensitivity assay in pediatric malignancies

AU - Rosanda, C.

AU - Garaventa, A.

AU - Pasino, M.

AU - Strigini, P.

AU - De Bernardi, B.

PY - 1987

Y1 - 1987

N2 - A short-term in vitro chemosensitivity test has been applied to 131 specimens from 109 children with various malignancies. The clinical outcome was correlated with in vitro percentage inhibition (PI) of DNA synthesis by the drug tested. In 62 correlations, PIs of responsive and of resistant patients differed significantly, with a cuf-off value of 37%. The test predicted clinical resistance in 53/54 cases, with a specificity of 98%, and clinical response in 8/8 cases, with a sensitivity of 100%. This test can be useful particularly in predicting chemoresistance in relapsing patients, to avoid unnecessary toxicity.

AB - A short-term in vitro chemosensitivity test has been applied to 131 specimens from 109 children with various malignancies. The clinical outcome was correlated with in vitro percentage inhibition (PI) of DNA synthesis by the drug tested. In 62 correlations, PIs of responsive and of resistant patients differed significantly, with a cuf-off value of 37%. The test predicted clinical resistance in 53/54 cases, with a specificity of 98%, and clinical response in 8/8 cases, with a sensitivity of 100%. This test can be useful particularly in predicting chemoresistance in relapsing patients, to avoid unnecessary toxicity.

UR - http://www.scopus.com/inward/record.url?scp=0023615523&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023615523&partnerID=8YFLogxK

M3 - Article

VL - 7

SP - 365

EP - 367

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 3 B

ER -